Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - Sanomedics, Inc. | simh_ex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) March 11, 2013
Sanomedics International Holdings, Inc.
(Exact name of registrant as specified in its charter)
|
Delaware
|
000-54167
|
27-3320809
|
||
|
(State or other jurisdiction
of incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
|
80 SW 8th Street, Suite 2180, Miami, Florida
|
33130
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant's telephone number, including area code (305)433-7814
not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective March 8, 2013 Dom Gatto resigned as the Chief Executive Officer .
On March 8, 2013, the Board of Directors of Sanomedics appointed William Lerner as a member of the Board of Directors (the Board). Sanomedics currently anticipates that Mr. Lerner will serve on Sanomedics Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee, when those committees are formed. Sanomedics anticipates entering into an Indemnification Agreement with Mr. Lerner.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
99.1 Press release of the Company, dated March 8, 2013
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Sanomedics International Holdings, Inc. | |||
|
Date: March 11, 2013
|
By: |
/s/ David C. Langle
|
|
|
David C. Langle,
Chief Financial Officer
|
|||
3